| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/05/2000 | EP0726894B1 Short-acting dihydropyridines |
| 07/05/2000 | EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 07/05/2000 | CN1259143A Oligosaccharide mixtures having antithrombotic activity |
| 07/05/2000 | CN1259140A Treatment of insulin resistance with growth hormone secretagogues |
| 07/05/2000 | CN1259137A Estra-5(10), 7-dienes with estrogenic activity |
| 07/05/2000 | CN1258675A Process and intermediate for producing 5-lipoxidase inhibitor |
| 07/05/2000 | CN1258536A Heart activating capsule |
| 07/05/2000 | CN1258532A Medicated cosmetics capable of being used to treat primary and secondary varicose vein simultaneously and its preparation |
| 07/05/2000 | CN1258527A Fast-acting piles-treating Chinese medicine preparation |
| 07/05/2000 | CN1258526A Three-leaf tea |
| 07/05/2000 | CN1258521A Medicine for treating cardiac and cerebral vascular diseases and its preparation |
| 07/05/2000 | CN1054074C Compound gingko leaf preparation and its producing process |
| 07/05/2000 | CN1054072C Hypotensor and its preparing method |
| 07/05/2000 | CN1054061C Powder for treating hypertension for external use |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6083991 Anti-arrhythmic composition and methods of treatment |
| 07/04/2000 | US6083987 Phenylenediamine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant |
| 07/04/2000 | US6083986 Amine derivative substituted indane compound useful for the treatment of cardiac arrhythmias and cell proliferative disorders |
| 07/04/2000 | US6083974 Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them |
| 07/04/2000 | US6083971 Certain oxopyrolo-pyrrole derivatives having thrombin inhibiting activity |
| 07/04/2000 | US6083960 Constrained somatostatin agonists and antagonists |
| 07/04/2000 | US6083955 Having a high affinity for drugs, especially endoserine receptors |
| 07/04/2000 | US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083920 Treating nervous system disorders by administering lysocerebroside or lysosphingomyelin |
| 07/04/2000 | US6083706 Inhibitors of leaderless protein export |
| 07/04/2000 | US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein |
| 07/04/2000 | US6083497 Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| 07/04/2000 | CA2116565C Low speed model following velocity command system for rotary wing aircraft |
| 07/04/2000 | CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 07/04/2000 | CA2002337C Controlled release flecainide acetate formulation |
| 07/04/2000 | CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037641A2 Vascular endothelial growth factor-x |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037637A1 Novel protein and dna thereof |
| 06/29/2000 | WO2000037616A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
| 06/29/2000 | WO2000037481A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb¿1? |
| 06/29/2000 | WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 06/29/2000 | WO2000037469A2 Process for preparing n6-substituted deaza-adenosine derivatives |
| 06/29/2000 | WO2000037463A1 S-oxide lipid lowering compounds |
| 06/29/2000 | WO2000037456A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 06/29/2000 | WO2000037450A1 NEW β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS |
| 06/29/2000 | WO2000037441A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | WO2000037436A1 Sulfonamide hydroxamates |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/29/2000 | WO2000037423A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |
| 06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
| 06/29/2000 | WO2000037112A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | WO2000037095A1 Cardiac muscle function and manipulation |
| 06/29/2000 | WO2000037094A2 Therapeutic applications of flint polypeptides |
| 06/29/2000 | WO2000037086A1 Agonists and antagonists of peripheral-type benzodiazepine receptors |
| 06/29/2000 | WO2000037082A1 Use of 5-ht7 receptor antagonists for treating neuronal degeneration resulting from ischemic events |
| 06/29/2000 | WO2000037077A1 Assays for ligands for nuclear receptors |
| 06/29/2000 | WO2000037062A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents |
| 06/29/2000 | WO2000037059A2 Compositions and methods to inactivate n-type calcium channels |
| 06/29/2000 | WO2000037025A2 Antibodies to truncated vegf-d and uses thereof |
| 06/29/2000 | WO2000023447B1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties |
| 06/29/2000 | WO2000015237A9 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases |
| 06/29/2000 | WO2000013687A3 Sustained release ranolazine formulations |
| 06/29/2000 | WO2000012497A3 Quinazoline derivatives as medicaments |
| 06/29/2000 | WO2000012118A3 Inhibiting cardiomyocyte death |
| 06/29/2000 | WO2000002543A3 Antihypersensitive combination of valsartan and calcium channel blocker |
| 06/29/2000 | WO2000000610A3 Human signal peptide-containing proteins |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/29/2000 | WO1999063974A3 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues |
| 06/29/2000 | DE19954305A1 Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie Peptides of AT¶1¶ receptor and their use, in particular for pre-eclampsia Diagnostider |
| 06/29/2000 | CA2358508A1 Therapeutic applications of flint polypeptides |
| 06/29/2000 | CA2357760A1 Process for preparing n6-substituted deaza-adenosine derivatives |
| 06/29/2000 | CA2356887A1 Assays for ligands for nuclear receptors |
| 06/29/2000 | CA2356460A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 06/29/2000 | CA2356174A1 Kidney disease detection and treatment |
| 06/29/2000 | CA2356159A1 Novel spla2 inhibitors |
| 06/29/2000 | CA2355968A1 Novel protein and dna thereof |
| 06/29/2000 | CA2355902A1 Sulfonamide hydroxamates |
| 06/29/2000 | CA2355896A1 Antibodies to truncated vegf-d and uses thereof |
| 06/29/2000 | CA2355879A1 Pharmaceutical compositions comprising immortalised endothelial cells |
| 06/29/2000 | CA2355874A1 .alpha.v.beta.6 integrin inhibitors |
| 06/29/2000 | CA2355861A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 06/29/2000 | CA2355822A1 S-oxide lipid lowering compounds |
| 06/29/2000 | CA2355704A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | CA2355251A1 New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists |
| 06/29/2000 | CA2355074A1 Lymphocytic membrane proteins |
| 06/29/2000 | CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 06/29/2000 | CA2333626A1 Method for prevention and treatment of cancer and other cell proliferative diseases with ultrasonics |
| 06/29/2000 | CA2293081A1 Restenosis drug therapy |
| 06/28/2000 | EP1013760A2 Stable bactericidal/permeabilityincreasing protein products and pharmaceutical compositions containing the same |
| 06/28/2000 | EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit |
| 06/28/2000 | EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 06/28/2000 | EP1013278A1 The extract of pine needle and the use thereof |
| 06/28/2000 | EP1013275A2 Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
| 06/28/2000 | EP1012329A1 Diagnosis and treatment of myocardial failure |
| 06/28/2000 | EP1012296A2 Mammalian thioredoxin |
| 06/28/2000 | EP1012292A1 Ntn-2 member of tnf ligand family |
| 06/28/2000 | EP1012291A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis |
| 06/28/2000 | EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them |
| 06/28/2000 | EP1012267A2 An antisense oligonucleotide preparation method |